SUPEMTEK

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug SUPEMTEK contains a combination of these active pharmaceutical ingredients (APIs):

1 Influenza A virus subtype H1N1 haemagglutinin, recombinant

Read about Influenza, inactivated, surface antigen

2 Influenza A virus subtype H3N2 haemagglutinin, recombinant

Read about Influenza, inactivated, surface antigen

3 Influenza B virus Victoria lineage haemagglutinin, recombinant

Read about Influenza, inactivated, surface antigen

4 Influenza B virus Yamagata lineage haemagglutinin, recombinant

Read about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1833791, 1833803, 1833814, 1834466, 1834477, 1834488
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 395663, 395861
Country: IT	Agenzia del Farmaco	Identifier(s): 049227010, 049227022, 049227034, 049227046, 049227059, 049227061
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091345, 1091346, 1091347, 1091348, 1091349, 1091350
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100445839